Acute optic neuritis Optic neuritis is the commonest cause of spontaneously reversible visual loss in young adults in populations of Northern European origin. It usually begins with discomfort around the eye which is increased by eye movement. Blurring of vision usually follows within a few days though it may precede the pain, which is only rarely severe. Visual loss evolves over a week or so to reach a maximum which varies from the trivial to the profound (no perception of light). Colour vision is altered early, colours being broken up in a pointillist manner, as MacKarell,2 a professional painter, has so poignantly illustrated. It soon fades so that the environment has a pale, grey, washed out appearance (fig 1) . The general level of illumination appears low and depth perception is impaired.
Clinical findings Examination at the height of the symptoms reveals a variable loss of acuity, though it is usually worse than 6/24. The classical field loss is a central scotoma, but .it is important to appreciate that a range of defects may be found, to some extent depending on rarely be the presenting feature of multiple sclerosis. This variability in vision is associated with a reduction in amplitude of the visual evoked potential,7 and can be partly accounted for by the extreme sensitivity of conduction in partially demyelinated fibres to small changes in temperature. 8 A sense of disorientation in moving traffic is experienced by some patients and is probably due to the Pulfrich effect, a phenomenon attributable to unequal latencies between the two eyes which can be experienced in normal individuals by placing a neutral density filter over one eye: a pendulum swinging in one plane then appears to be describing an elipse. 9 10 Course and prognosis The patient with optic neuritis is anxious to have answers to two questions: "Will I get better?" and "Will it recur?" The physician (and sometimes the patient too) is also inter-Abnormalities of the afferent visual system co----nw-O -_ _ _ ested in the question: "Will the patient develop multiple sclerosis?" Between 85-95% of patients with acute optic neuritis make an excellent recovery to an acuity of 6/9 or better over a period of 1-3 months, though occasionally the recovery period is longer. Even if the final acuity is normal, patients may be aware of a range of residual symptoms, which are not, however, usually troublesome except when the patient's occupation or recreation requires optimum visual performance. Impairment of contrast sensitivity and colour vision are common" and impairment of depth perception may interfere with playing ball games.
It is not possible to predict the likelihood of a residual deficit with any confidence on clinical grounds. Gould et al, for example, found that the worst visual acuity was unrelated to the likelihood of a persisting deficit. '2 Recently, MRI of the optic nerve has provided evidence that physically long lesions (more than 1 cm), particularly when they involve the portion of the nerve in the optic canal, are significantly associated with persistent visual impairment. ' The dependence of visual acuity on intact optic nerve conduction as assessed by VEP amplitude, but not latency, is well established . 34 These experiments lead to the conclusion that the inflammatory process per se impairs conduction and that its resolution makes an important contribution to visual recovery. The possible mechanisms involved are reviewed by Youl et al. 33 Demyelination probably does, however, contribute to some symptoms. The Pulfrich effect can be accounted for by slowing of conduction in one optic nerve, and the phosphenes on eye movement by abnormal excitability of demyelinated axons.35The high risk ofpersistent visual impairment with lesions in the optic canal may be due to the occurrence of inflammation with accompanying oedema in a region where there is little room for expansion of the nerve. The ophthalmic artery also runs through the canal, and it is possible that the lasting deficit results from the addition of an ischaemic element to the direct effects of inflammation and demyelination.
Treatment
Given that approximately 90% of patients make an excellent spontaneous recovery it will be difficult to demonstrate a therapeutic effect the end-point of which is a reduction in the number of patients with persisting visual loss. This is indeed the case, and no completed study is large enough to demonstrate such an effect. One might, however, expect steroids to be helpful in view of their anti-inflammatory properties and their capacity to reverse the blood-brain barrier defect (albeit temporarily) in multiple sclerosis.36 Several studies have shown that treatment with ACTH3738 and retrobulbar triamcinolone"2 shortens the duration of visual impairment. In view of the influence that length of the lesion and involvement of the nerve in the bony optic canal have on prognosis, a controlled trial of high dose intravenous methylprednisolone in this sub group has been initiated. A large multicentre trial of oral prednisone on unselected cases of optic neuritis is being carried out in the United States.
Acute bilateral optic neuritis We have so far dealt only with acute unilateral optic neuritis. In adults, acute bilateral simultaneous optic neuritis is much less common than unilateral or sequential optic neuritis, and published studies are based on small numbers. Hierons and Lyle reported 11 cases who were reviewed after up to 30 years by Parlin et al. 39 40 The visual prognosis was poorer than for unilateral optic neuritis. Only two patients fulfilled the criteria for a diagnosis of multiple sclerosis, suggesting that this disease may be less common after simultaneously bilateral optic neuritis than after unilateral optic neuritis. Nevertheless, we see a few cases each year in whom multiple sclerosis follows acute bilateral simultaneous optic neuritis. The numbers in this study were small and the possibility that some of the patients were isolated cases of Leber's optic neuropathy could not, at that time, be excluded. 
